LK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung Cancer
Clinical trial NCT05886439 · RECRUITING
Trial details
- NCT number
- NCT05886439
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-11
- Primary completion
- 2027-05-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.